1. Home
  2. NWTG vs HOOK Comparison

NWTG vs HOOK Comparison

Compare NWTG & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWTG
  • HOOK
  • Stock Information
  • Founded
  • NWTG 2018
  • HOOK 2011
  • Country
  • NWTG United States
  • HOOK United States
  • Employees
  • NWTG N/A
  • HOOK N/A
  • Industry
  • NWTG Recreational Games/Products/Toys
  • HOOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • NWTG Consumer Discretionary
  • HOOK Health Care
  • Exchange
  • NWTG Nasdaq
  • HOOK Nasdaq
  • Market Cap
  • NWTG 8.3M
  • HOOK 9.3M
  • IPO Year
  • NWTG N/A
  • HOOK 2019
  • Fundamental
  • Price
  • NWTG $1.96
  • HOOK $0.85
  • Analyst Decision
  • NWTG
  • HOOK Buy
  • Analyst Count
  • NWTG 0
  • HOOK 4
  • Target Price
  • NWTG N/A
  • HOOK $10.67
  • AVG Volume (30 Days)
  • NWTG 7.2M
  • HOOK 38.5K
  • Earning Date
  • NWTG 05-02-2025
  • HOOK 05-08-2025
  • Dividend Yield
  • NWTG N/A
  • HOOK N/A
  • EPS Growth
  • NWTG N/A
  • HOOK N/A
  • EPS
  • NWTG N/A
  • HOOK N/A
  • Revenue
  • NWTG $3,445,000.00
  • HOOK $43,946,000.00
  • Revenue This Year
  • NWTG $53.58
  • HOOK N/A
  • Revenue Next Year
  • NWTG $58.36
  • HOOK N/A
  • P/E Ratio
  • NWTG N/A
  • HOOK N/A
  • Revenue Growth
  • NWTG 887.11
  • HOOK 118.32
  • 52 Week Low
  • NWTG $1.35
  • HOOK $0.72
  • 52 Week High
  • NWTG $195.00
  • HOOK $10.50
  • Technical
  • Relative Strength Index (RSI)
  • NWTG N/A
  • HOOK 39.54
  • Support Level
  • NWTG N/A
  • HOOK $0.73
  • Resistance Level
  • NWTG N/A
  • HOOK $0.85
  • Average True Range (ATR)
  • NWTG 0.00
  • HOOK 0.08
  • MACD
  • NWTG 0.00
  • HOOK 0.03
  • Stochastic Oscillator
  • NWTG 0.00
  • HOOK 77.25

About NWTG Newton Golf Company Inc. Common Stock

Newton Golf Co is a technology-forward golf company dedicated to revolutionizing the sport with cutting-edge, high-performance products. The company's expanding portfolio includes golf shafts, putters, grips, and other golf-related accessories designed for golfers of all skill levels. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf, as well as through mass merchants and corporate customers in the Americas, Asia, and Europe.

About HOOK HOOKIPA Pharma Inc.

HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.

Share on Social Networks: